In this study 1-[4-(2-methoxy benzyl)-6-aryl-pyridazin-3(2H)-ylidene] hydrazines were used for the synthesis of new heterocyclic systems such as thiazolidine, phthalazine, pyrazolo, tetrazolo, hydrazide and new pyridazine derivatives to explore the effect of silver nanoparticles on their biological activity efficiency. Structures of the new heterocycles were characterized by the aid of several analytical techniques including; 1 H-NMR, FTIR and mass spectra. Silver nanoparticles were synthesized by a simple methodology and the formation of silver nanoparticles was confirmed by transmission electron microscopy (TEM) and UV studies. Most of the new prepared heterocycles were evaluated in vitro as new antimicrobial agents. Combination effects of the silver nanoparticles on the antimicrobial activity of the new heterocycles were investigated using the disk diffusion method. Compound 10a exhibited the strongest enhancing effect of silver nanoparticles solution against Aspergillus flavus and Candida albicans.
Introduction
Nanoparticles are emerging materials that have a broad range of applications and notable characteristics different from those of bulk materials. They often have specific optical and electronic properties 1 and chemical reactivity. 2 Silver nanoparticles (Ag-NPs or nanosilver) are one of the most widely used nanoparticles, most notably serving as an antimicrobial agent for medical applications. The toxicity of nanosilver may be explained by the interaction of nanoparticles with microbes involving silver ion release and particle cellular internalization. 3, 4 Sizedependent toxicity of nanosilver 5, 6, 7 supports the mode of action of Ag-NPs. The nanosilver toxicity is species specific. Smallsized Ag-NPs can inhibit nitrifying bacterial growth more than silver ions at the same total silver concentrations. 6, 8 However, Ag-NPs are not as effective as Ag ions in killing Escherichia coli. 8 Over the past decade; there has been a strong push towards the development of silver-containing materials for commercial use that exhibit antimicrobial or bactericidal properties. Research has been intensive in antibacterial material containing various natural and inorganic substances. 9 Among them, silver or silver ions have long been known to have strong inhibitory and bactericidal effects as well as a broad spectrum of antimicrobial activities. 10, 11 Several proposals have been developed to explain the inhibitor effects of silver ion/silver metal on bacteria. It is generally believed that heavy metals react with proteins by combining the thiol (SH) groups, which leads to the inactivation of the proteins. 12 Recent, microbiological and chemical experiments implied that interaction of silver ion with thiol groups played an essential role in bacterial inactivation. 13 Also, it is revealed that bulk silver in an oxygen-charged aqueous media catalyzes the complete destructive oxidation of microorganisms. 14 Metal nanoparticles (Me-NPs), which have a high specific surface area and a high fraction of surface atoms have been studied extensively because of their unique physicochemical characteristics including catalytic activity, optical properties, electronic properties, antimicrobial activity, and magnetic properties. [15] [16] [17] Among Me-NPs, silver nanoparticles (AgNPs) have been known to have inhibitory and bactericidal effects. 18 It can be expected that the high specific surface area and high fraction of surface atoms of Ag-NPs will lead to high antimicrobial activity as compared with bulk silver metal. 18 The combined effects of Ag-NPs with the antibacterial activity of antibiotics have not been studied. The ability of pathogenic bacteria to resist antimicrobial agents has emerged in recent years and is a major health problem.
Pyridazines are an important class of heterocycles, which have been the subject of extensive research, particularly in the pharmaceutical and agrochemical areas and their synthesis and applications have been comprehensively reviewed. [21] [22] [23] Pyridazines including mono-and bicyclic derivatives have attracted much attention due to their potential biological activities. 24 The recent advances in combinatorial chemistry and high throughput screening have confirmed the tremendous importance of heterocycles as templates in the search for novel pharmacologically useful low molecular weight compounds. 25, 26 Heterocycles bearing nitrogen, sulfur and thiazole moieties constitute the core structure of a number of biologically interesting compounds. 27 In continuation of our research for the synthesis of series of new biologically active heterocycles, [28] [29] [30] [31] the purpose of this study was to design and synthesis new heterocycles using hydrazine pyridazine derivatives 1a-d as key materials and investigate the preliminary screening for antibacterial and antifungal activities for some of the new heterocycles using silver nanoparticles (Ag-NPs) to study the combination effect of silver nanoparticles solution on their biological activity. Refluxing of 1a-d with unsaturated aliphatic aldehyde such as crotonaldehyde in ethanol gave the corresponding hydrazones 5a-d. The structures of 5a-d were inferred from their elemental analysis and spectral data. Its IR spectra of 5a-d displayed bands at 1533 -1544 (C=C), 1596 -1603 (C=N), 2905 -2911 (CH aliphatic) and 3171 -3199 cm -1 (NH) respectively (Scheme 2). In a routine in vitro screening for cytotoxic activity, phthalazine showed significant tumor cell growth inhibition. 33 In this study, we synthesized fused heterocyclic compound such as phthalazine derivative 7 from solid phase reaction of 1c with 2-benzoyl benzoic acid. The structure of the phthalazine derivative 7 was confirmed from its elemental analysis and spectral data. The 13 Tetrazolo pyridazines are known to undergo tautumeric transformation, the tetrazole ring can break to form the azide group, or vice versa. 34 While the azide-tetrazolo tautomerism is relevant to a group of medicinal drugs, where the azide group is responsible for the mechanism of the drug activity. 35 Thus in the present study tetrazolo derivatives 9a-d were achieved by the cyclization of 3-hydrazino pyridazine derivatives 1a-d using nitrous acid which underwent tautomeric transformation via the tetrazole ring opening to form the azide group or vice versa. The presence of the double bond (C=C) in compounds 5a and 10a were confirmed chemically from the Enone reaction of products 5a and 10a with maleic anhydride to give the expected products 6, 13. The structures of 6, 13 were established other than elemental analysis and mass spectra. Their IR spectra show- To confirm the formation of silver nanoparticles in this solution, we carried out an UV-visible absorption study and TEM imaging. In Fig. 1 , a strong characteristic absorption peak around 400 nm is noted for the silver nanoparticles in the solution due 
Staphylococcus aureus
Escherichia coli to the surface plasmon resonance effect. Observation of this strong but broad surface plasmon peak has been well documented for various Ag-NPs size. [37] [38] [39] Transmission electron microscopy (TEM) images of the AgNPs solution which showed different size of Ag-NPs (Figure 2) were recorded using a Zeiss Electron Microscope 10, operating at power 60 kV. TEM samples were prepared by dispersing 2 -3 drops of Ag-NPs solution on copper grid and dried at room temperature after removal of excess solution using a filter paper.
A solution of compounds 4a, 8a,b, 10a, 11b and 12b were stirred with Ag-NPs solution, the residue products obtained in nano form were confirmed by (TEM) which showed different size of nano particles (Figures 3-6) .
Microbial experimentation. Microbial investigations were done to find the effect of some newly synthesized compounds against (Gram +ve) Staphylococcus aureus ATCC (12600) and (Gram -ve) bacteria Escherichia coli ATCC (11775), in addition to their antifungal activity against Aspergillus flavus and Candida albicans with or without silver nanoparticles (Ag-NPs) solution. The preliminary studies of the biological assay were performed according to the agar diffusion method [40] [41] [42] [43] at a concentration (20 mg/mL) using CHCl 3 or DMSO as solvents. The results of the in vitro antimicrobial activity were recorded as average diameter of inhibition zone in mm, are given in Table 1 , 2. Antibacterial activity. The combination effect of silver nanoparticles (Ag-NPs) solution with different compounds was investigated against Staphylococcus aureus and Escherichia coli using the diffusion method. [40] [41] [42] [43] The diameter of inhibition zones (in millimeters) around the different compounds disks with or without Ag-NPs against test strains are shown in Table 1 .
The antibacterial activities of 8b, 10a and 11b increased in the presence of Ag-NPs solution against both test strains. No enhancing effect of 4a on the antibacterial activities against Staphylococcus aureus and Escherichia coli. The highest fold increases in area were observed for 8b, 10a and 12b in presence of Ag-NPs against Staphylococcus aureus. In contrast, the highest fold increase in area was observed for 8b against Escherichia coli.
Antifungal activity. The antifungal activities of 10a increased in presence of Ag-NPs solution against Aspergillus flavus and Candida albicans. No enhancing effect on the antifungal activities of 9c and 12b in presence of Ag-NPs against Aspergillus flavus and Candida albicans was observed. The highest fold increases in area were observed for 8b and 11b in presence of Ag-NPs solution against Candida albicans, but they had no effect against Aspergillus flavus.
Conclusion
The current study involved the design and synthesis of new heterocycles based on pyridazin moiety using simple synthetic route to evaluate their antimicrobial and antifungal activities, and study the effect of silver nanoparticles solution on their biological activities. The study showed that the antimicrobial activity of compound 8b was the highest enhancing effect in the presence of silver nanoparticles solution against Staphylococcus aureus and Escherichia coli. -2-en-1-ylidene) Reduction of hydrazone derivatives 2a-c. A solution of compounds 2a-c (1 mmol) in mixture of (acetic anhydride/glacial acetic acid) (1:1) (20 mL) was refluxed with Zn (dust) (0.5 g) for 5 hrs. The reaction mixture was filtered on hot and poured onto ice. The solid product obtained was filtered, dried and crystallized from the appropriate solvent. Synthesis of silver-nanoparticles (Ag-NPs). The silver colloid was prepared by using chemical reduction method reported. 36 Silver nitrate (> 99%) and trisodium citrate dihydrate (99.0%) were purchased from Aldrich. All descriptions of water below refer to Nanopure deionized water (electrical resistance > 18.4 MΩ-cm), produced. Silver nanoparticles were prepared by citrate reduction of silver nitrate. AgNO3 (17.0 mg) was dissolved in 100 mL water in a 250 mL tri-neck flask. The solution was heated to boiling with a hemisphere heating mantle under vigorous magnetic stirring. After boiling for 2 minutes, an aqueous solution of sodium citrate (35 mM, 10 mL) was rapidly added to the flask. The solution gradually turned yellow within a few minutes, indicating the formation of Ag nanoparticles. The solution was kept boiling for an additional 6 minutes. After that, the heating mantle was removed, and the solution was allowed to cool. After cooling, a solution of compounds 4a, 8a,b, 10a, 11b and 12b (3 × 10 -3 gm soluble in 5 mL ethanol) was stirred with Ag-NPs solution (10 mL) for 24 hrs, after that the reaction mixture was evaporated and the solid product was obtained in the nano form.
1-[4-(2-Methoxybenzyl)-6-methylphenylpyridazin-3(2H)-ylidene]-2-((E)butan

1-[4-(2-Methoxybenzyl)-6-chlorophenylpyridazin-3(2H)-ylidene]-2-((E)butan-2-en-1-ylidene) hydrazine (5c):
1-[4-(2-Methoxybenzyl)-6-methoxyphenylpyridazin-3(2H)-ylidene]-2-((E)butan-2-en-1-ylidene) hydrazine (5d):
3-[4-(2-Methoxybenzyl)-6-phenylpyridazin-3(2H)-ylideneamino]-2-(4-nitrophenyl)-thiazolidin-4-one (3a):
3-[4-(2-Methoxybenzyl)-6-methylphenylpyridazin-3(2H)-ylidene-amino]-2-(4-nitrophenyl)-thiazolidin-4-one (3b):
1-[4-(2-Methoxybenzyl)-6-phenylpyridazin-3(2H)-ylidene]-2-(4-acetamidobenzyl) hydrazines (4a):
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